• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Dypyridamole

CAS No. 58-32-2

Dypyridamole ( NSC 515776 | NSC 619103 )

产品货号. M15141 CAS No. 58-32-2

双嘧达莫(Persantine)是一种磷酸二酯酶抑制剂,可阻断红细胞和血管内皮细胞对腺苷的摄取和代谢。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
10MG ¥112 有现货
25MG ¥157 有现货
50MG ¥216 有现货
100MG ¥293 有现货
500MG ¥482 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥125 有现货

生物学信息

  • 产品名称
    Dypyridamole
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    双嘧达莫(Persantine)是一种磷酸二酯酶抑制剂,可阻断红细胞和血管内皮细胞对腺苷的摄取和代谢。
  • 产品描述
    Dipyridamole (Persantine) is a phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells.(In Vitro):Dipyridamole (5 μM; 15 min) results in a 2.5-fold increase in intracellular cAMP levels in OCI-AML-3 cells.Dipyridamole (5 μM; 48 h) with the statin combination induces apoptosis in primary AML cells.Dipyridamole (5 μM; 48 h) possesse cAMP/PKA-independent activity against statininduced SREBP2 activation.(In Vivo):Dipyridamole (10 mg/kg; p.o. once daily for 18 d) mitigates tumor growth, ameliorated concurrent alterations in blood circulation and tumor tissues, and platelet infiltration in tumor tissues.
  • 体外实验
    Dipyridamole (5 μM; 15 min) results in a 2.5-fold increase in intracellular cAMP levels in OCI-AML-3 cells.Dipyridamole (5 μM; 48 h) with the statin combination induces apoptosis in primary AML cells.Dipyridamole (5 μM; 48 h) possesse cAMP/PKA-independent activity against statininduced SREBP2 activation. Apoptosis Analysis Cell Line:AML (OCI-AML-2, OCI-AML-3) cell line Concentration:5 μM Incubation Time:48 h Result:Induced apoptosis with the combination of fluvastatin and dipyridamole, cilostazol, forskolin, or dbcAMP in OCI-AML-2 and OCI-AML-3 cells.RT-PCRCell Line:LP1 cell line Concentration:5 μM Incubation Time:16 h Result:Increased the sensibility of cancer cells to statin-induced apoptosis.
  • 体内实验
    Dipyridamole (10 mg/kg; p.o. once daily for 18 d) mitigates tumor growth, ameliorated concurrent alterations in blood circulation and tumor tissues, and platelet infiltration in tumor tissues. Animal Model:C57BL/6-LLC tumor-bearing mice models Dosage:10 mg/kg Administration:Oral gavage; 10 mg/kg; once daily for 18 days Result:Mitigated tumor growth in tumor-bearing mice.
  • 同义词
    NSC 515776 | NSC 619103
  • 通路
    Angiogenesis
  • 靶点
    PDE
  • 受体
    PDE| PDE
  • 研究领域
    Cardiovascular Disease
  • 适应症
    ——

化学信息

  • CAS Number
    58-32-2
  • 分子量
    504.63
  • 分子式
    C24H40N8O4
  • 纯度
    >98% (HPLC)
  • 溶解度
    Ethanol: 50 mg/mL (99.08 mM); DMSO: 101 mg/mL (200.14 mM)
  • SMILES
    OCCN(CCO)C1=NC(N2CCCCC2)=C(N=C(N(CCO)CCO)N=C3N4CCCCC4)C3=N1
  • 化学全称
    2,2',2'',2'''-((4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl)bis(azanetriyl))tetraethanol

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Fujishige K, et al. J Biol Chem. 1999 Jun 25;274(26):18438-45.
产品手册
关联产品
  • PF‐04447943

    一种有效、选择性、脑渗透性、口服活性的 PDE9A 抑制剂,IC50 为 8.3 nM。

  • Cilostazol

    Cilostazol (OPC 13013, OPC 21) 是一种有效的 PDE3A 抑制剂,IC50 为 0.2 uM;抑制血小板聚集,在体内具有显着的抗血栓作用。

  • Tadalafil

    他达拉非是一种有效的磷酸二酯酶 5 (PDE5) 抑制剂 (IC50=1 nM)。